Pharmafile Logo

Rob Jones

- PMLiVE

Study finds doctors have difficulty diagnosing disease in images of darker skin

Researchers have found that AI could be used to more accurately diagnose these patients

- PMLiVE

Imagine More for the reporting of consensus programme outputs

The Bedrock team reflects on the latest published guidance in the development of consensus programmes

Bedrock Healthcare Communications

- PMLiVE

Therapy Watch launches new tracker covering pulmonary arterial hypertension (PAH)

Therapy Watch Pulmonary Arterial Hypertension (PAH) is launching in the US market, with expansion into other geographies including Europe in 2024.

Inizio

- PMLiVE

Hitting Every Beat—The Power of Education in Heart Failure

Heart failure can be a challenge to manage both for clinicians and patients. It’s a complex condition with various manifestations and presentations, and different disease stages that require different approaches...

Medscape Education

- PMLiVE

Medscape Education Wins Best Practice in Advancing Diversity, Equity, and Inclusion in Medical Education at the 19th Annual NAMEC Best Practice Awards

Medscape Education was a co-recipient of the inaugural Best Practice in Advancing Diversity, Equity, and Inclusion in Medical Education award at the 19th Annual NAMEC Best Practice Awards!Creating education that...

Medscape Education

- PMLiVE

GSK’s RSV vaccine granted FDA priority review for use in adults aged 50 to 59 years

Arexvy has already been approved in the US and Europe to protect those aged 60 years and older

- PMLiVE

Researchers suggest erectile dysfunction drugs could reduce risk of Alzheimer’s

The study found that men prescribed PDE5Is were 18% less likely to develop the disease

- PMLiVE

Vertex shares positive late-stage results for triple combination cystic fibrosis treatment

The company compared the treatment to its current triple cystic fibrosis therapy

- PMLiVE

ABPI publishes manifesto for government to accelerate UK life sciences industry

The trade association has called on political parties to commit to three broad goals and requirements

- PMLiVE

Johnson & Johnson and Protagonist’s JNJ-2113 shows promise in plaque psoriasis

The immune-mediated disease is estimated to affect more than 125 million people worldwide

- PMLiVE

Wilmington Healthcare promotes Sarah Hawkins to operations director

Hawkins has worked in B2B strategic marketing for over 30 years across a variety of industries

- PMLiVE

Wilmington Healthcare promotes Julian Snape to head of consultancy

Snape has over 30 years of experience in the UK life sciences industry

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links